These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38914626)

  • 21. The Changing Detection Rate of Respiratory Syncytial Virus in Adults in Western Australia between 2017 and 2023.
    Foley DA; Minney-Smith CA; Tjea A; Nicol MP; Levy A; Moore HC; Blyth CC
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of public health measures and new introducing variants on Respiratory syncytial virus recrudescence in Taiwan during the COVID-19 pandemic.
    Lee CY; Wu TH; Fang YP; Chang JC; Wang HC; Lin SJ; Mai CH; Chang YC
    J Clin Virol; 2023 Sep; 166():105531. PubMed ID: 37473610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resurgence of human respiratory syncytial virus during COVID-19 pandemic in Southern Brazil.
    Fröhlich GC; Gregianini TS; Pinheiro FG; Nascimento R; Cezar TM; Pscheidt VM; Selayaran T; Martins LG; Gomes MFDC; Salvato RS; Pereira EC; Guimarães-Ribeiro V; Scalioni LP; Siqueira MM; Resende PC; Veiga ABG;
    J Med Virol; 2024 Mar; 96(3):e29551. PubMed ID: 38506236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the Potential Drivers for Respiratory Syncytial Virus Rebound During the Coronavirus Disease 2019 Pandemic.
    Li Y; Wang X; Cong B; Deng S; Feikin DR; Nair H
    J Infect Dis; 2022 Mar; 225(6):957-964. PubMed ID: 35030633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Three Multiplex Real-time Reverse Transcription PCR Assays for Simultaneous Detection of SARS-CoV-2, Influenza A/B, and Respiratory Syncytial Virus in Nasopharyngeal Swabs.
    Yun J; Park JH; Kim N; Roh EY; Shin S; Yoon JH; Kim TS; Park H
    J Korean Med Sci; 2021 Dec; 36(48):e328. PubMed ID: 34904407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term effects of non-pharmaceutical interventions on total disease burden in parsimonious epidemiological models.
    Fung T; Goh J; Chisholm RA
    J Theor Biol; 2024 Jun; 587():111817. PubMed ID: 38599566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early and intense epidemic of respiratory syncytial virus (RSV) in Denmark, August to December 2022.
    Munkstrup C; Lomholt FK; Emborg HD; Møller KL; Krog JS; Trebbien R; Vestergaard LS
    Euro Surveill; 2023 Jan; 28(1):. PubMed ID: 36695451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resurgence of respiratory syncytial virus infection during COVID-19 pandemic in Pune, India.
    Bhardwaj S; Choudhary ML; Chadha MS; Kinikar A; Bavdekar A; Gujar N; Dcosta P; Kulkarni R; Bafna S; Salvi S; Padbidri V; Potdar V
    BMC Infect Dis; 2024 Jun; 24(1):586. PubMed ID: 38877428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. During the COVID-19 pandemic where has respiratory syncytial virus gone?
    Di Mattia G; Nenna R; Mancino E; Rizzo V; Pierangeli A; Villani A; Midulla F
    Pediatr Pulmonol; 2021 Oct; 56(10):3106-3109. PubMed ID: 34273135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic.
    Williams TC; Sinha I; Barr IG; Zambon M
    Euro Surveill; 2021 Jul; 26(29):. PubMed ID: 34296673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decline of influenza and respiratory syncytial virus detection in facility-based surveillance during the COVID-19 pandemic, South Africa, January to October 2020.
    Tempia S; Walaza S; Bhiman JN; McMorrow ML; Moyes J; Mkhencele T; Meiring S; Quan V; Bishop K; McAnerney JM; von Gottberg A; Wolter N; Du Plessis M; Treurnicht FK; Hellferscee O; Dawood H; Naby F; Variava E; Siwele C; Baute N; Nel J; Reubenson G; Zar HJ; Cohen C
    Euro Surveill; 2021 Jul; 26(29):. PubMed ID: 34296675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulation of influenza, RSV, and SARS-CoV-2: an uncertain season ahead.
    Burki TK
    Lancet Respir Med; 2021 Oct; 9(10):e103. PubMed ID: 34370976
    [No Abstract]   [Full Text] [Related]  

  • 33. Off-season RSV epidemics in Australia after easing of COVID-19 restrictions.
    Eden JS; Sikazwe C; Xie R; Deng YM; Sullivan SG; Michie A; Levy A; Cutmore E; Blyth CC; Britton PN; Crawford N; Dong X; Dwyer DE; Edwards KM; Horsburgh BA; Foley D; Kennedy K; Minney-Smith C; Speers D; Tulloch RL; Holmes EC; Dhanasekaran V; Smith DW; Kok J; Barr IG;
    Nat Commun; 2022 May; 13(1):2884. PubMed ID: 35610217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deviations in RSV epidemiological patterns and population structures in the United States following the COVID-19 pandemic.
    Rios-Guzman E; Simons LM; Dean TJ; Agnes F; Pawlowski A; Alisoltanidehkordi A; Nam HH; Ison MG; Ozer EA; Lorenzo-Redondo R; Hultquist JF
    Nat Commun; 2024 Apr; 15(1):3374. PubMed ID: 38643200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seasonality, Clinical Characteristics, and Outcomes of Respiratory Syncytial Virus Disease by Subtype Among Children Aged <5 Years: New Vaccine Surveillance Network, United States, 2016-2020.
    Toepfer AP; Amarin JZ; Spieker AJ; Stewart LS; Staat MA; Schlaudecker EP; Weinberg GA; Szilagyi PG; Englund JA; Klein EJ; Michaels MG; Williams JV; Selvarangan R; Harrison CJ; Lively JY; Piedra PA; Avadhanula V; Rha B; Chappell J; McMorrow M; Moline H; Halasa NB
    Clin Infect Dis; 2024 May; 78(5):1352-1359. PubMed ID: 38366649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RSV genomic diversity and the development of a globally effective RSV intervention.
    Kim S; Williams TC; Viboud C; Campbell H; Chen J; Spiro DJ
    Vaccine; 2021 May; 39(21):2811-2820. PubMed ID: 33895016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RSV reemergence in Argentina since the SARS-CoV-2 pandemic.
    Dolores A; Stephanie G; Mercedes S NJ; Érica G; Mistchenko AS; Mariana V
    J Clin Virol; 2022 Apr; 149():105126. PubMed ID: 35299101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of Human Parainfluenza Virus Type 3 and Respiratory Syncytial Virus Infections in the Time of Coronavirus Disease 2019: Findings From a Household Cohort in Maryland.
    Hetrich MK; Oliva J; Wanionek K; Knoll MD; Lamore M; Esteban I; Veguilla V; Dawood FS; Karron RA;
    Clin Infect Dis; 2023 Apr; 76(8):1349-1357. PubMed ID: 36503986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of non-pharmacologic interventions on respiratory syncytial virus hospitalization during the COVID-19 pandemic: A retrospective study from Saudi Arabia.
    AlBahrani S; Al Otaibi TO; Alqahtani JS; AlZahrani SJ; Sharbini DA; AlMuyidi FW; Alotaibi AO; Olayan OAA; AlMasoud SF; Bo Obaid MAH; Altawfiq KJA; Jebakumar AZ; Al-Tawfiq JA
    J Infect Public Health; 2024 Jan; 17(1):96-101. PubMed ID: 37992439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiological features of pediatric viral respiratory infection during the COVID-19 pandemic in Taiwan.
    Hsu HT; Huang FL; Ting PJ; Chang CC; Chen PY
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):1101-1107. PubMed ID: 34756671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.